 | Up a level |
Journal Article
Deubzer, H., Fabian, J., Opitz, D., Althoff, K., Lodrini, M., Astrahantseff, K., Hero, B., Volland, R., Beckers, A., De Preter, K., Patil, N., Abba, M., Wuenchel, J., Thole, T., Hu, J., Schweitzer, L., Mechtersheimer, G., Carter, D., Cheung, B., Popanda, O., von Deimling, A., Henrich, K. O., Westermann, F., Schwab, M., Koster, J., Versteeg, R., Marshall, G., Speleman, F., Zoeller, M., Allgayer, H., Fischer, M., Berthold, F., Kulozik, A., Witt, O., Schulte, J. and Eggert, A. (2015). MYCN TRANSCRIPTIONALLY REPRESSES CD9 TO TRIGGER AN INVASION-METASTASIS CASCADE IN NEUROBLASTOMA. Pediatr. Blood Cancer, 62. S. S150 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
Hsin, C. H., Kinzig, M., Schaeffeler, E., Lenssen, R., Taubert, M., Trueck, C., Gazzaz, M., Quasdorff, M., Schwab, M., Soergel, F., Stoffel, M. and Fuhr, U. (2018). Lack of mutual pharmacokinetics DDIS for a novel transporter phenotyping cocktail. Naunyn-Schmiedebergs Arch. Pharmacol., 391. S. S44 - 1. NEW YORK: SPRINGER. ISSN 1432-1912
Hsin, C. H., Stoffel, M., Gazzaz, M., Schaeffeler, E., Schwab, M., Li, X., Fuhr, U. and Taubert, M. (2020). Haplotypes of the transporter gene ABCB1 influence apparent bioavailability, but not renal elimination of oral digoxin. Naunyn-Schmiedebergs Arch. Pharmacol., 393 (SUPPL 1). S. 78 - 79. NEW YORK: SPRINGER. ISSN 1432-1912
Trueck, C., Gazzaz, M., Kinzig, M., Schaeffeler, E., Kinzig, M., Juebner, M., Hsin, C. H., Li, X., Taubert, M., Iltgeb-Breburda, J., Kraus, D., Queckenberg, C., Stoffel, M., Schwab, M., Soergel, F. and Fuhr, U. (2018). A cocktail study to assess pharmacokinetic interactions of acute ethanol intake. Naunyn-Schmiedebergs Arch. Pharmacol., 391. S. S24 - 1. NEW YORK: SPRINGER. ISSN 1432-1912
Wolking, S., Stapleton, C., Schulz, H., Nies, A., McCormack, M., Schubert, J., Schwab, M., Sander, T., Cavalleri, G. and Lerche, H. (2017). THE IDENTIFICATION FOR PHARMACOGENETIC BIOMARKERS IN THE TREATMENT OF EPILEPSY. Epilepsia, 58. S. S119 - 1. HOBOKEN: WILEY. ISSN 1528-1167
von Tresckow, B., Goebeler, M. E., Sayehli, C., Gundermann, S., Eichenauer, D., Aulitzky, W., Bacchus, L., Igel, S., Schwab, M., Sasse, S., Hauns, B., Mais, A., Hentsch, B., Kohlhof, H., Krauss, R., Krauss, B., Baumgartner, R., Vitt, D. and Engert, A. (2014). FIRST-IN-MAN STUDY OF 4SC-202, A NOVEL ORAL HDAC INHIBITOR IN PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES; (TOPAS STUDY). Haematologica, 99. S. 711 - 712. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078